Your browser doesn't support javascript.
loading
Reprogramming of tumor-associated macrophages by targeting ß-catenin/FOSL2/ARID5A signaling: A potential treatment of lung cancer.
Sarode, Poonam; Zheng, Xiang; Giotopoulou, Georgia A; Weigert, Andreas; Kuenne, Carste; Günther, Stefan; Friedrich, Aleksandra; Gattenlöhner, Stefan; Stiewe, Thorsten; Brüne, Bernhard; Grimminger, Friedrich; Stathopoulos, Georgios T; Pullamsetti, Soni Savai; Seeger, Werner; Savai, Rajkumar.
Afiliación
  • Sarode P; Max Planck Institute for Heart and Lung Research, Member of the German Center for Lung Research (DZL), Member of the Cardio-Pulmonary Institute (CPI), Bad Nauheim 61231, Germany.
  • Zheng X; Max Planck Institute for Heart and Lung Research, Member of the German Center for Lung Research (DZL), Member of the Cardio-Pulmonary Institute (CPI), Bad Nauheim 61231, Germany.
  • Giotopoulou GA; Laboratory for Molecular Respiratory Carcinogenesis, Department of Physiology, Faculty of Medicine, University of Patras, Rio, 26504, Greece and Lung Carcinogenesis Laboratory, Comprehensive Pneumology Center (CPC) and Institute for Lung Biology and Disease (iLBD), University Hospital, Ludwig-Maximi
  • Weigert A; Institute of Biochemistry I, Faculty of Medicine, Goethe University Frankfurt, Frankfurt 60323, Germany.
  • Kuenne C; Max Planck Institute for Heart and Lung Research, Member of the German Center for Lung Research (DZL), Member of the Cardio-Pulmonary Institute (CPI), Bad Nauheim 61231, Germany.
  • Günther S; Max Planck Institute for Heart and Lung Research, Member of the German Center for Lung Research (DZL), Member of the Cardio-Pulmonary Institute (CPI), Bad Nauheim 61231, Germany.
  • Friedrich A; Max Planck Institute for Heart and Lung Research, Member of the German Center for Lung Research (DZL), Member of the Cardio-Pulmonary Institute (CPI), Bad Nauheim 61231, Germany.
  • Gattenlöhner S; Department of Pathology, Member of the DZL, Justus Liebig University, Giessen 35390, Germany.
  • Stiewe T; Institute of Molecular Oncology, Philipps-University Marburg, Member of the DZL, Marburg 35043, Germany.
  • Brüne B; Institute of Biochemistry I, Faculty of Medicine, Goethe University Frankfurt, Frankfurt 60323, Germany.
  • Grimminger F; Frankfurt Cancer Institute (FCI), Goethe University, 60596 Frankfurt am Main, Germany.
  • Stathopoulos GT; Department of Internal Medicine, Member of the DZL, Member of CPI, Justus Liebig University, 35392 Giessen, Germany.
  • Pullamsetti SS; Laboratory for Molecular Respiratory Carcinogenesis, Department of Physiology, Faculty of Medicine, University of Patras, Rio, 26504, Greece and Lung Carcinogenesis Laboratory, Comprehensive Pneumology Center (CPC) and Institute for Lung Biology and Disease (iLBD), University Hospital, Ludwig-Maximi
  • Seeger W; Max Planck Institute for Heart and Lung Research, Member of the German Center for Lung Research (DZL), Member of the Cardio-Pulmonary Institute (CPI), Bad Nauheim 61231, Germany.
  • Savai R; Department of Internal Medicine, Member of the DZL, Member of CPI, Justus Liebig University, 35392 Giessen, Germany.
Sci Adv ; 6(23): eaaz6105, 2020 06.
Article en En | MEDLINE | ID: mdl-32548260
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Beta Catenina / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Sci Adv Año: 2020 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Beta Catenina / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Sci Adv Año: 2020 Tipo del documento: Article País de afiliación: Alemania